Combination of Suture‐Plug Vascular Closure Devices Versus Suture‐Only Devices Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta‐Analysis
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31655 ↗At a glance
Systematische Übersicht in Catheterization and Cardiovascular Interventions, 2025. Written by Saddik Haddad and 2 co-authors. Institution: Faculty of Medicine, Tishreen University, Latakia, Syria. Major MEDLINE topics: Transcatheter Aortic Valve Replacement, Vascular Closure Devices, Hemostatic Techniques, Aortic Valve Stenosis. Cited 2 times so far (Crossref); 22 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Transcatheter aortic valve implantation (TAVI) is an effective and safe intervention for severe symptomatic aortic stenosis regardless of surgical risk. Vascular complications following TAVI are considered among the most common and serious complications, with a higher risk of mortality.
Aims
We aimed to perform a systematic review and meta‐analysis to evaluate the safety and efficacy of the combination of suture‐collagen plug vascular closure devices (VCDs) compared with suture‐only devices.
Methods
We have systematically searched the literature from inception until January 4, 2025, for cohort studies and clinical trials comparing the combination of suture‐collagen plug vascular closure devices (VCDs) versus suture‐only VCDs.
Results
A total of 2064 patients across six studies were included in the analysis. All studies compared dual Perclose ProGlide versus 1 Perclose ProGlide + 1 Angio‐Seal, except one study that used either one Prostar or dual ProGlide in the suture group. The combination group of suture‐plug VCDs was associated with a statistically significant reduction of VCDs failure (RR = 0.14, CI 95% [0.09–0.23], p < 0.0001, I 2 = 58.6938%), bleeding complications (RR = 0.35, CI95% [0.24–0.53], p < 0.0001, 0.0%), major vascular complications (RR = 0.42, CI 95% [0.28, 0.63], p < 0.0001, I 2 = 50.4%), and minor vascular complications (RR = 0.54, CI 95% [0.43, 0.66], p < 0.0001, I 2 = 0%). On the other hand, all‐cause mortality did not have a statistically significant difference between the two groups (RR = 0.54, CI 95% [0.28, 1.05], p = 0.0709, I 2 = 0%).
Conclusions
In patients undergoing TAVI, the combination strategy of suture‐plug VCDs is superior to suture‐only devices regarding major and minor vascular complications, bleeding complications, and VCD failure. The significantly higher VCD failure of the suture‐only group observed in our study led to the use of additional closure devices to secure hemostasis, raising concerns about a higher risk of peripheral ischemia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Faculty of Medicine, Tishreen University, Latakia, Syria.
- Cancer Research Center, Tishreen University, Latakia, Syria.
- Keele Cardiovascular Research Group, Keele University, Keele, UK.
ORCID profiles: Saddik Haddad, George Bashour, Mamas A Mamas
Funding
- The authors received no specific funding for this work.
Cite
APA
Haddad, S., Bashour, G., & Mamas, M. A. (2025). Combination of Suture‐Plug Vascular Closure Devices Versus Suture‐Only Devices Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31655
Vancouver
Haddad S, Bashour G, Mamas MA. Combination of Suture‐Plug Vascular Closure Devices Versus Suture‐Only Devices Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31655
BibTeX
@article{Haddad2025,
author = {Haddad, Saddik and Bashour, George and Mamas, Mamas A},
title = {Combination of Suture‐Plug Vascular Closure Devices Versus Suture‐Only Devices Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta‐Analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31655}
}
EUVIMED